13S169: Abstracts: Sjögren's Syndrome – Basic and Clinical Science (1625–1628)

Abstract Moderator(s)

• GN

  Gaetane Nocturne, MD, PhD

  APHP
  Le Kremlin Bicetre, France

  Disclosure(s): Amgen: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Novartis: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
• MB

  Matthew Basiaga, MS, DO, RhMSUS

  Mayo Clinic
  Rochester, MN, United States

  Disclosure(s): Childhood Arthritis and Rheumatology Research Alliance: Grant/Research Support (Ongoing); Sjogren's Foundation: Grant/Research Support (Ongoing)

Oral abstract session.

Presentations:

• 5:00 PM – 5:10 PM Eastern Time

  Single Cell and Spatial Transcriptomics Identifies Pathogenic Drivers of Sjogren’s Disease in Humans
  

  Presenting Author: Dr. Blake M. Warner, PhD, MPH, DDS – National Institutes of Health
• 5:10 PM – 5:15 PM Eastern Time

  Q&A
  
• 5:15 PM – 5:25 PM Eastern Time

  Unique Biological Profile of Germinal Centres Within Tertiary Lymphoid Structures in the Salivary Glands of Patients with Sjögren’s Syndrome
  

  Presenting Author: SABA NAYAR, PhD – University of Birmingham
• 5:25 PM – 5:30 PM Eastern Time

  Q&A
  
• 5:30 PM – 5:40 PM Eastern Time

  BAFF-var Is a New Predisposing Factor for Primary Sjögren’s Syndrome (pSS) and Impacts Disease Activity
  

  Presenting Author: Marie Dulin, MD – INSERM UMR1184
• 5:40 PM – 5:45 PM Eastern Time

  Q&A
  
• 5:45 PM – 5:55 PM Eastern Time

  The Sjogren Tool for Assessing Response (STAR): Assessment of Response Rates Overall, According to Baseline Activity and by Domain: Reanalysis of 9 Clinical Trials in Primary Sjogren Syndrome
  

  Presenting Author: Raphaele Seror, MD, PhD – university hospital Paris Saclay
• 5:55 PM – 6:00 PM Eastern Time

  Q&A